Related references
Note: Only part of the references are listed.Silibinin Retards Colitis-associated Carcinogenesis by Repression of Cdc25C in Mouse Model
Weiwei Li et al.
INFLAMMATORY BOWEL DISEASES (2019)
Membrane-Anchored Serine Proteases and Protease-Activated Receptor-2-Mediated Signaling: Co-Conspirators in Cancer Progression
Nisha R. Pawar et al.
CANCER RESEARCH (2019)
Ubiquitination of Rheb governs growth factor-induced mTORC1 activation
Lu Deng et al.
CELL RESEARCH (2019)
The lysosome as a cellular centre for signalling, metabolism and quality control
Rosalie E. Lawrence et al.
NATURE CELL BIOLOGY (2019)
Lysosomal membrane permeabilization as a cell death mechanism in cancer cells
Ana Serrano-Puebla et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2018)
Ameliorating mitochondrial dysfunction restores carbon ion-induced cognitive deficits via co-activation of NRF2 and PINK1 signaling pathway
Yang Liu et al.
REDOX BIOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Protease-activated receptor 2 signaling modulates susceptibility of colonic epithelium to injury through stabilization of YAP in vivo
Longmei He et al.
CELL DEATH & DISEASE (2018)
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
Delphine Merino et al.
CANCER CELL (2018)
From tumour heterogeneity to advances in precision treatment of colorectal cancer
Cornelis J. A. Punt et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
AT-101 enhances gefitinib sensitivity in non-small cell lung cancer with EGFR T790M mutations
Ren Zhao et al.
BMC CANCER (2016)
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
Aaron N. Hata et al.
NATURE MEDICINE (2016)
Bcl-xL is an oncogenic driver in colorectal cancer
Anna-Lena Scherr et al.
CELL DEATH & DISEASE (2016)
Proteinase-activated Receptor 2 Promotes Cancer Cell Migration through RNA Methylation-mediated Repression of miR-125b
Lan Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial
Christophe Tournigand et al.
LANCET ONCOLOGY (2015)
The Ubiquitination of RagA GTPase by RNF152 Negatively Regulates mTORC1 Activation
Lu Deng et al.
MOLECULAR CELL (2015)
The Phyre2 web portal for protein modeling, prediction and analysis
Lawrence A. Kelley et al.
NATURE PROTOCOLS (2015)
Clinical Significance of GAB2, a Scaffolding/Docking Protein Acting Downstream of EGFR in Human Colorectal Cancer
Tae Matsumura et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
The rheostat in the membrane: BCL-2 family proteins and apoptosis
N. Volkmann et al.
CELL DEATH AND DIFFERENTIATION (2014)
Proteinase-activated Receptor 2 (PAR2) Decreases Apoptosis in Colonic Epithelial Cells
Vadim Iablokov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previously Untreated, Unresectable, Wild-Type KRAS Exon 2 Metastatic Colorectal Cancer
Lee S. Schwartzberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Protein Phosphatase 6 Controls BCR-Induced Apoptosis of WEHI-231 Cells by Regulating Ubiquitination of Bcl-xL
Ryutaro Kajihara et al.
JOURNAL OF IMMUNOLOGY (2014)
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
Volker Heinemann et al.
LANCET ONCOLOGY (2014)
Proteinase-activated Receptor-2 Transactivation of Epidermal Growth Factor Receptor and Transforming Growth Factor-β Receptor Signaling Pathways Contributes to Renal Fibrosis
Hyunjae Chung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110)
J. Y. Suen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Bacterial proteases in IBD and IBS
Natalie Steck et al.
GUT (2012)
Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Protein-induced Lysosomal Translocation of Proapoptotic Effectors Is Mediated by Phosphofurin Acidic Cluster Sorting Protein-2 (PACS-2)
Nathan W. Werneburg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Targeting proteinase-activated receptors: therapeutic potential and challenges
Rithwik Ramachandran et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Prognostic significance of Bcl-xL gene expression in human colorectal cancer
Jin-Song Yang et al.
ACTA HISTOCHEMICA (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways as Therapeutic Targets for Colorectal Cancer
Thomas Winder et al.
GASTROENTEROLOGY (2010)
RNF152, a novel lysosome localized E3 ligase with pro-apoptotic activities
Songling Zhang et al.
PROTEIN & CELL (2010)
Significance of Bcl-xL in human colon carcinoma
You-Li Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Programmed anuclear cell death delimits platelet life span
Kylie D. Mason et al.
CELL (2007)
Differential expression of Bcl-2, Bcl-XL and p53 in colorectal cancer
Hye Seung Han et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation
Roberta Caruso et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Drug therapy - Systemic therapy for colorectal cancer
JA Meyerhardt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Protease-activated receptor 2 in colon cancer - Trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation
D Darmoul et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer -: Clinical and experimental findings
A Biroccio et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Translocation of SAPK/JNK to mitochondria and interaction with Bcl-xL in response to DNA damage
S Kharbanda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Proteinase-activated receptor-2-mediated matrix metalloproteinase-9 release from airway epithelial cells
A Vliagoftis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
Share Paper
